Comprehensive Dermatologic Drug Therapy

Inbunden, Engelska, 2020

1 594 kr

Beställningsvara. Skickas inom 5-8 vardagar. Fri frakt över 249 kr.

Beskrivning

**Selected for 2026 Doody's Core Titles in Dermatology**

Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th Edition, helps you safely and effectively treat the skin disorders you’re likely to see in your practice. Dr. Stephen E. Wolverton and new associate editor Dr. Jashin J. Wu lead a team of global experts to bring you concise, complete guidance on today's full spectrum of topical, intralesional, and systemic drugs. You’ll prescribe with confidence thanks to expert coverage of which drugs to use, when to use them, and adverse effects to monitor.

Produktinformation

Utgivningsdatum:2020-05-18
Mått:216 x 276 x 34 mm
Vikt:2 540 g
Format:Inbunden
Språk:Engelska
Antal sidor:858
Upplaga:4
Förlag:Elsevier Health Sciences
ISBN:9780323612111

Utforska kategorier

Dermatologi inom Medicin

Recensioner i media

Doody's Core Titles® 2022"I highly recommend this book. Having this reference in the medical library will make it a snap for dermatologists to be at the top of their game." --Patricia Wong, MD (Private Practice) Doody's Review Service: 94-4 Stars!

Innehållsförteckning

Part I: Introduction1. Basic Principles of Pharmacology2. Principles for Maximizing the Safety of Dermatologic Drug Therapy3. Polymorphisms: Why Individual Drug Responses Vary4. Adherence to Drug Therapy5. Medical Decision MakingPart II: Important Drug Regulatory Issues6. The FDA Drug Approval Process7. Pharmacovigilance: Verifying that Drugs Remain Safe8. Drugs Taken Off the Market: Important Lessons LearnedPart III: Systemic Drugs for Infectious Diseases9. Systemic Antibacterial Agents10. Systemic Antifungal Agents11. Systemic Antiviral Agents12. Systemic Antiparasitic AgentsPart IV: Systemic Immunomodulatory Drugs13. Systemic Corticosteroids14. Methotrexate15. Azathioprine16. Mycophenolates17. Cyclosporine18. Phosphodiesterase-4 and Janus Kinase Inhibitors19. Cytotoxic Agents20. Dapsone21. Antimalarial Agents22. Systemic RetinoidsPart V: Drugs Used in Conjunction with UV or Visible Light23. Psoralen Plus Ultraviolet A Photochemotherapy and Other Phototherapy Modalities24. Extracorporeal Photochemotherapy (Photopheresis)25. Photodynamic TherapyPart VI: Biologic Therapeutics26. Tumor Necrosis Factor Inhibitors27. Interleukin 12/23 Inhibitors28. Interleukin 17 Inhibitors29. Interleukin 23 Inhibitors30. Rituximab31. Additional Biologic Therapeutics: Dupilumab, Omalizumab, OthersPart VII: Miscellaneous Systemic Drugs32. Antihistamines33. Vasoactive and Antiplatelet Agents34. Antiandrogens and Androgen Inhibitors35. Psychotropic Agents36. Intravenous Immunoglobulin Therapy37. Systemic Anticancer Agents: Dermatologic Indications and Adverse Events38. Hedgehog Pathway Inhibitors39. Drugs for the Skinternist40. Miscellaneous Systemic DrugsPart VIII: Topical Drugs for Infectious Diseases41. Topical Antibacterial Agents42. Topical Antifungal Agents43. Topical and Intralesional Antiviral Agents44. Topical Antiparasitic AgentsPart IX: Topical Immunomodulatory Drugs45. Topical Corticosteroids46. Topical Retinoids47. Topical and Intralesional Chemotherapeutic Agents48. Topical Calcineurin Inhibitors49. Topical Vitamin D3Part X: Miscellaneous Topical Drugs50. Sunscreens51. Therapeutic Shampoos52. ?-Hydroxy Acids53. Chemical Peels54. Products for the Care of Chronic Wounds55. Agents Used for Treatment of Hyperkeratosis56. Irritants and Allergens: When to Suspect Topical Therapeutic Agents57. Miscellaneous Topical AgentsPart XI: Injectable and Mucosal Routes of Drug Administration58. Local Anesthetics59. Injectable Dermal and Subcutaneous Fillers60. Botulinum Toxin Injections61. Oral Mucosal TherapeuticsPart XII: Major Adverse Effects From Systemic Drugs62. Hepatotoxicity of Dermatologic Drug Therapy63. Hematologic Toxicity of Drug Therapy64. Drug-induced Malignancy65. Dermatologic Drugs During Pregnancy and Lactation66. Drug Interactions67. Cutaneous Drug Reactions With Systemic FeaturesPart XIII: Special Pharmacology and Therapeutics Topics68. Informed Consent and Risk Management69. Compounding in Dermatology70. Dermatologic Drug Therapy in ChildrenAppendixI Core Questions for Understanding Systemic Dermatologic DrugsII The Most Potentially Serious Drug Interactions